Wednesday, September 01, 2021 6:23:53 AM
I’m certainly not telling anyone to try to time the peak. People should have a price in mind or a timeline in mind.
Some buy to only sell in retirement or to give to their heirs.
Some people buy and have a goal of the results like I want to make 50% on my money and they sell, and pick something else they want 50% on.
I have prices where I will take profits on the way up and many people do. Some will ride it to the top and sell on the way down.
But all these tactics do not combine date and time like if it hits $5 on dec 31, 2033 I will sell.
It’s more like, I want $4.25 and I want to sell X shares and then I will sell X shares at $6.25 and if it takes 6 years that is okay.
For me, my historical move was if I overbuy a stock, and it goes up 400% past my average, I sell 25% to take my initial investment out. And sometimes I sell 50% and sometimes I start selling at 200% if I think it may correct.
I have different strategies on different companies because of my belief on where it could go and when and what I think will cause it to get there. If it runs fast before I think it should I might sell 90% even at what I guess is the top.
For instance $fdbl has such a low market cap that I believe it could run 10x when they really get the wind behind them. Heck it could run 100x if the platform is sold to another company.
I’ve already made 15,000 on it from the 400% run it did earlier and when it corrected I bought 1.9million shares. And if it runs to .10 I will be very happy and will take profits along the way.
If it goes out of business, I’ve already taken profits before and I will have broken even.
It will suck if it does not run again as I expect, but I have no idea when. If I had bought more at the recent bottom I would have sold some on the spike this last week.
So it depends. You watch. You strategize. You build a plan and stick with it or update it based on new information. And watch for pitfalls. And don’t invest more than you can afford to lose.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM